Richmond Pharmacology Ltd is the largest provider of Caucasian/Japanese Bridging Studies in Europe. We are also the largest Phase I and II CRO in the UK.
We are delighted to announce that we have opened a new facility at Mayday University Hospital to complement our units and offices in St George’s Hospital and St George’s University of London. This ground breaking move means Richmond Pharmacology is the UK’s first CRO with a dedicated Phase I and clinical trials unit to be based in 2 acute NHS Teaching Hospitals.